Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 1/2 2

Status

Completed 38Terminated 11Unknown 4Withdrawn 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × ibritumomab tiuxetan × Clear all
NCT01811368 2022-11-30

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

University of California, Davis

Phase 2 Unknown
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT00772655 2012-08-02

Zevalin® First Line in Follicular Lymphoma

Charite University, Berlin, Germany

Phase 2 Unknown
60 enrolled
Lymphoid

Lymphoma, Follicular

NCT00722930 2008-07-28

GOTEL-FL1LC

Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas

Phase 2 Unknown
38 enrolled
Lymphoid

Lymphoma, Follicular

NCT00438581 2007-02-27

Zevalin

McGill University

Phase 2 Unknown
40 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡